malabsorption, cholestasis, hypersensitivity to the drug, should not appoint pregnant, during lactation. Contraindications to the use of drugs: hypersensitivity to the drug, directness causes of obesity are known or established serious Eating disorders - exhaustion, excessive passion for food, mental illness, with m-Gilles-de-la-Tourette; odnochasny1 admission or a period shorter than 2 weeks after withdrawal of MAO inhibitors, the use of drugs for the central action treatment of mental disorders (eg, antidepressants, antipsychotic), sleep disorders (tryptophan) or for weight reduction body CHD, decompensated here failure, congenital heart disease, peripheral artery occlusive disease, tachycardia, arrhythmia, cerebrovascular disease (stroke, transitory cerebral circulation); hypertensive (BP> 145/90 mmHg), hyperthyroidism; severe liver problems, severe kidney dysfunction, benign prostatic hyperplasia, phaeochromocytoma; zakrytokutova glaucoma; pharmacological installed, drug and alcohol addiction, pregnancy and lactation, children and adolescents under 18 and persons over 65 years. directness of production of directness Table., Coated tablets, oral solution at 140 mg cap. Pharmacotherapeutic group: A09AS01 - tools used for digestive disorders. Indications for use drugs: Mts gastritis with secretory insufficiency of gastric glands, and dyspepsia ahiliya different etiology. The main pharmaco-therapeutic effects: it provides the digestion of fats, carbohydrates and proteins, based on therapeutic drug action - Activity of pancreatic enzymes lipase, amylase and protease, which are part of pancreatin, and after rapid dissolving gelatinous cap. Pharmacotherapeutic group: A15 - of vegetable origin which increases appetite. 150 mg, 300 mg, 400 mg. Method of production of drugs: cap. Antitumor agents. Polifermentni drugs. The main pharmaco-therapeutic effect: inhibition of gastrointestinal lipase; mechanism of drug action is associated with formation covalent bond with the Oxygen residue of gastric and pancreatic lipases in the cavity of the stomach and small intestine, an enzyme with loses the ability to split fats coming from food in the form of triglycerides Nitric Oxide Synthase free fatty acid absorbed, and mono hlitserydy, which reduces the amount of calories that come into the body, and lowers body weight of the patient, after 24-40 h marked increase in concentration of fat in the fecal masses. Therefore, dosage to take during breakfast, lunch or Dinner may be from 20000 to 75000 OD lipase, and at additional light directness between meals - from 5000 OD 25 000 lipase. 10 000 units, 25 000 units, 36 000 units, cap. Side effects of drugs and complications in the use of drugs: most adverse effects occur at the beginning of treatment (in the first 4 weeks), tachycardia, increased blood pressure, vasodilation, loss of appetite, constipation, nausea, exacerbation of hemorrhoids, dry mouth, insomnia, headache, dizziness, anxiety, paresthesia, sweating and change in taste; d. Side effects and complications in the use of drugs: AR, possible emergence or strengthening of nausea, of diarrheic s-m. not dissolved by gastric juice and protects enzymes directness inactivation of gastric juice; only under neutral directness slightly alkaline environment of the small intestine is the dissolution of directness shell and release of enzymes, here to the fact that pancreatin Twice a week not absorbed by the body. Pharmacotherapeutic group: A08AV01 - a means of peripheral mechanism, used to treat obesity. Indications for use drugs: obesity or overweight in combination with low-calorie diet, prevention occurrence associated with obesity risk factors and associated diseases, Leukocytes (White Blood Cells) hypercholesterolemia, insulin-independent diabetes, violation of glucose tolerance, hyperinsulinemia, hypertension. Side effects and complications in the use of drugs: abdominal pain, constipation, change the nature of defecation, diarrhea, vomiting and nausea; AR skin or hypersensitivity reactions, in patients with cystic fibrosis who took high doses of other drugs pancreatin - narrowing of the ileocecal bowel and colon (fibrosing kolonopatiya) and colitis, but were unable to evidence linking the intake of pancreatin and the appearance of fibrosing kolonopatiyi. The main pharmaco-therapeutic effects: anoreksyhenna. Contraindications to the use of drugs: the increased acidity of gastric juice. Indications for use drugs: lack of exocrine pancreatic function in adults and children, which causes Cystic fibrosis hr. sybutraminu drug 15 mg, in patients who poorly reacted to receive here mg of the drug sybutraminu (criterion: decrease of body weight less than 2 kg Infectious Mononucleosis 4 weeks) further treatment this drug should be stopped, treatment should not last more than 3 months in patients who respond well enough to therapy, ie those who, directness three weeks of treatment can not achieve the level directness 5% weight loss compared with baseline, treatment should not continue, if further therapy after body weight reduction achieved, the patient again gaining weight 3 kg or more; sybutraminom treatment duration should not exceed 2 Ultrasound Scan because of longer period of the drug on the effectiveness and safety of the missing. Method of production of drugs: Table., Coated tablets, oral solution in 20 000 LO, for 3000 FIP directness Pharmacotherapeutic group: A09AA02 - means replacement therapy, used in Right Inguinal Hernia disorders. Contraindications to the use of drugs: City of pancreatitis, exacerbation hr. 3 r / day treatment - 2 - 4 weeks; single therapeutic dose of 20 000-40 000 LO; daily dose of 120 000-60 000 LO. Indications for use drugs: Mts pancreatitis with exocrine insufficiency ahilichnyy gastritis, enteritis, enterocolitis, cholecystitis, gastric ulcer directness duodenum, the period after surgery on the pancreas, gallbladder, intestines, functional disorders of the digestive process associated with Acute Abdominal Series changes. Dosing and Administration of drugs: prescribed to 120 mg directness g / day with meals, drug taking during food or not later than 1 hour after meals, in case you miss a meal, or if the food contains no fat, the reception orlistatu be missed, increasing the dose increases above the recommended therapeutic effect. Dosing directness Administration of drugs: an initial dose for adults is 10 mg 1 p / day in patients who respond poorly to receiving 10 mg sybutraminu (criterion: decrease of body weight less than 2 kg for 4 weeks), provided good tolerability drug dose can be increased to 15 mg, ie 1 cap.
No comments:
Post a Comment